WO2013184812A1 - Preventing inadvertent changes in ambulatory medical devices - Google Patents
Preventing inadvertent changes in ambulatory medical devices Download PDFInfo
- Publication number
- WO2013184812A1 WO2013184812A1 PCT/US2013/044329 US2013044329W WO2013184812A1 WO 2013184812 A1 WO2013184812 A1 WO 2013184812A1 US 2013044329 W US2013044329 W US 2013044329W WO 2013184812 A1 WO2013184812 A1 WO 2013184812A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- input
- infusion pump
- ambulatory infusion
- processor
- safe mode
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/048—Interaction techniques based on graphical user interfaces [GUI]
- G06F3/0484—Interaction techniques based on graphical user interfaces [GUI] for the control of specific functions or operations, e.g. selecting or manipulating an object, an image or a displayed text element, setting a parameter value or selecting a range
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
Definitions
- Portable ambulatory medical devices have proved useful for treating patients with medical conditions that require continuous monitoring and/or treatment.
- One example of such a portable ambulatory medical device is a device that involves the delivery of fluids.
- fluids including liquids and gases, that have a beneficial effect when administered in known and controlled quantities. This is particularly true in the medical field, where treatments for many of patients include the administration of a known amount of a substance at predetermined intervals.
- the treatment of diabetes involves just such a regimented dosage of medicaments such as insulin.
- diabetes is one of a few medical indications wherein patients routinely administer the medicament to themselves by a subcutaneous modality, such as a hypodermic syringe injection or by an ambulatory infusion pump.
- a subcutaneous modality such as a hypodermic syringe injection or by an ambulatory infusion pump.
- providing a patient with the means to safely, reliably, and comfortably administer required doses of medication such as, e.g., insulin, may be particularly important in order to facilitate patient compliance and accurate treatment of the condition.
- Ambulatory insulin infusion pumps have been developed for the administration of insulin for those diagnosed with both type I and type II diabetes.
- Ambulatory insulin pumps are medical infusion devices used for the administration of insulin in the treatment of diabetes, and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. They also allow for continuous insulin therapy.
- some ambulatory insulin infusion devices can include data collection and storage mechanisms, which allow a diabetic person and/or a doctor to easily monitor and adjust insulin intake.
- the infusion device may be powered by a rechargeable battery that requires periodic recharging.
- Some ambulatory medical devices include a touchscreen on which symbols may be displayed and from which inputs may be received for operation of the device.
- Other input mechanisms involve keyboards or hardware switches.
- a series of display screens or windows are shown on a device display or on the device touchscreen, showing alphanumeric text and symbols, and providing menu screens through which the user can control operation of the device.
- User interaction such as by touching the alphanumeric text and symbols, provides user input and facilitates navigation through the menu screens and selection of the device functions.
- a device includes an active mode in which the device receives a user input at an input interface of the device and provides the received user input to a processor of the device.
- the active mode can be terminated and the device operated in a safe mode, in which the received user input is not provided to the processor and/or one or more device function is disabled, in response to determining that the received user input was received in an out of bounds region of the input interface.
- the safe mode is terminated in response to receiving a predetermined user input comprising an activation input.
- the activation input can comprise selection of a wake display button or icon of the user interface, or may comprise a predetermined sequence of selected buttons or icons of the user interface.
- the activation input may be modified to require a timed pattern to wake the touchscreen.
- the pattern would require two or more presses that would be delivered in specified time windows, and if presses where detected outside of these windows, the sequence would be aborted.
- the portable device may include a user interface with control features such as buttons, switches or icons to control pumping and other functions, and the portable device may include a touchscreen on which are displayed alphanumeric text, symbols, menu screens, data, alerts, and other information.
- the device may show one or more screens or windows on the touchscreen through which device control inputs are received. For each device screen display, one or more regions of the display, and/or one or more buttons or switches, will be considered out of bounds for any intended control input.
- any user interaction with an out of bounds region can cause the active mode to be suspended and the device will be in a safe mode of operation in which at least one of the device components is not operated.
- the device will remain in the safe mode until it receives an activation input before permitting continued active operation.
- the activation input may comprise a sequence of multiple inputs from the user via the touchscreen or a group of multiple inputs provided simultaneously, such as multiple simultaneous button presses. Failure to receive the activation input will result in the device remaining in the safe mode.
- the activation input may require the user to comply with activation sequence parameters as to both multiple symbol interactions and time between the multiple interactions. Requiring the predetermined activation sequence before resuming normal operation reduces the likelihood of accidental or unintended activation of the portable ambulatory medical device and improves user safety.
- FIG. 1 depicts a portable device according to an embodiment of the present invention that is coupled to a patient for infusing medication thereto.
- FIG. 2 is a block diagram of circuitry and components for the portable medical device illustrated in FIG. 1.
- FIG. 3 is a flow diagram showing operations of the device in FIG. 1.
- FIG. 4 depicts a display screen with a home screen display showing out-of-bounds regions according to an embodiment of the present invention.
- FIG. 5 depicts a display screen with a data entry screen display showing out-of-bounds regions according to an embodiment of the present invention.
- FIG. 6 depicts a display screen with a confirmation screen display showing an out-of- bounds region according to an embodiment of the present invention.
- FIG. 7 depicts a display screen with an unlock screen display.
- the drawings illustrate embodiments of the technology and are not limiting. For clarity and ease of illustration, the drawings may not be made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
- an interactive display screen such as a touch screen
- FIG. 1 shows an electrically-powered portable device 100 that is coupled to a host power source 102, such as a desktop or laptop computer, through a cable 104.
- the cable may comprise, for example, a coupling through which both data and electrical energy are received at the portable device 100.
- Examples of such combined power and data cables include a Universal Serial Bus (USB) connection, an IEEE 1499 connection, a "THUNDERBOLT” connection (i.e., from Apple, Inc., of Cupertino, CA, USA), PCI Express, eSATA and Ethernet.
- the host power source 102 is a source of electrical energy and can be any type of computing device that includes a port 106 that receives a connector 108 of the cable 104.
- the port of the host computing device may comprise, for example, a USB port, or IEEE 1499 port, or port for THUNDERBOLT, PCI Express, eSATA or Ethernet.
- a compatible connector port 110 of the portable device 100 is coupled to the cable 104 at an opposite end 112 of the cable.
- the cable 104 is a USB cable and associated connections and ports may support one or more of USB version 1.1 , 2.0, or 3.0 data transfer speeds.
- the portable device 100 may be coupled to a patient 114 via an infusion port 116 and a connecting tube or cannula 118.
- the connecting tube is coupled to the portable device 100 at a fluid dispending port 120.
- the portable device may include control features, such as buttons or switches 121 to receive user input and control pumping and other features, and may include a display screen 122 on which are displayed messages and alerts.
- the display 122 may comprise, for example, a touchscreen on which user inputs may be received.
- a housing 124 of the portable device encloses internal components, such as fluid reservoirs, electrical components, battery, and the like.
- a portable medical device of the type worn by a patient 114 such that insulin fluid is delivered via the connecting tube 118 and the fluid dispensing port 120 by a delivery mechanism.
- Exemplary ambulatory medical devices and features include those, e.g., disclosed in U.S. Patent Application No. 13/557,163, U.S. Patent Application No. 12/714,299, U.S. Patent Application No. 12/538,018, U.S. Provisional Patent Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Patent No. 8,287,495.
- Each of the aforementioned documents is hereby incorporated herein by reference in its entirety.
- the portable device 100 can be coupled to a host power source such as a desktop or laptop computer, through a cable connected to the connector port 110.
- the cable may comprise, for example, a coupling through which both data and electrical energy are received at the portable device 100.
- Examples of such combined power and data cables include a Universal Serial Bus (USB) connection, an IEEE 1499 (Fire Wire) connection, a "THUNDERBOLT” connection (from Apple, Inc. of Cupertino, CA, USA), PCI Express, eSATA and Ethernet.
- the device 100 may also include a capability to operatively couple to one or more other devices via a wired or wireless (e.g., infrared, electronic, optical, etc.) link, locally or via a network, such as, e.g., a portable or non-portable medical device, a control unit, external monitor or display, a personal laptop, tablet or mainframe computer, or mobile communication device such as a smartphone or personal digital assistant (PDA).
- PDA personal digital assistant
- Such other devices may control or be controlled by device 100 and/or may otherwise communicate for the transfer of data including device parameters between or among device 100 and other device(s) for analysis of data (e.g., user data for physician review, device diagnostic data for troubleshooting or repair), programming, or other uses.
- the portable device 100 may include control features such as buttons, panels, screens, and/or switches to control the device, or any combination of such control features.
- the portable device 100 illustrated in Fig. 1 shows a touchscreen 122 on which can be displayed alphanumeric text, symbols, menu screens, data, alerts and the like for receiving control input.
- the portable device may include a processor with memory, wherein the processor executes program instructions to provide an operating system that supports programs that execute and provide the specified features.
- the touchscreen 122 may be interactive, wherein user input may be received such as by pressing the outer surface of the touchscreen.
- the touchscreen 122 may be configured to display menu screens or pages that allow the user to input data fields, e.g., select device parameters, so as to allow the program to produce a suggested delivery amount, rate, profile, and/or the like in an intuitive, manipulable, and/or graphic representation, thereby allowing the user to interact with the screen to shape the characteristic/form of the delivery amount, rate, and/or graphic delivery profile, e.g., by manipulating the delivery estimate or pattern displayed on the screen to effectuate the actual delivery.
- data fields e.g., select device parameters
- Device parameters provided by the portable infusion device may be presented on the display screen 122 as any number of objects, including one or more numeric and/or alphanumeric values, a range, a value or range that is presented in the form of a drop-down menu, a toggle that can be adjusted by the user, a graphical representation (e.g., icon) or an animated graphic.
- the value is a range of values that are presented on a screen of the display as a toggle, wherein the toggle may be adjusted upwards or downwards by the user swiping a finger over the screen to select the appropriate value range, e.g. appropriate range of amounts of medicament such as insulin to be delivered and/or the appropriate rate, time, or interval of medicament delivery.
- the values presented in the range may be adjusted by the processor (illustrated in FIG. 2). Other device parameters will be readily apparent to those skilled in the art.
- the type of touch screen 122 may vary as desired to be useful for a particular application, such as LCD displays, LED displays, plasma displays, organic LED (OLED) displays, and the like.
- the touchscreen 122 may be implemented with a capacitance screen, a resistive screen, or other such display/input technology.
- the portable device 100 may additionally include a keyboard or other input device known in the art for data entry, which may be separate from the display.
- FIG. 2 shows a block diagram of some of the components within the portable device 100 of FIG. 1.
- the portable device 100 includes a power management system 202 that is connected to the connector port 110 that receives a combined data/power cable, such as the USB cable 104 illustrated in FIG. 1. That is, the cable 104 has the capability of simultaneously providing electrical energy for charging and data transmission for communications.
- a connector interface 206 supports data exchange and receives electrical power through the connector port 110, and controls a connector data element 208 and a connector power element 210. The device may be powered by battery power in place of or in addition to the connector interface.
- the connector interface 206 passes data communications from the connector port 110 through the connector data element 208 to a system bus 212.
- the connector interface 206 passes electrical power from the connector port 110 through the connector power element 210 to a battery charger 214, which in turn is coupled to a battery 216 and which recharges the battery.
- he connector data element 208 is implemented in the FIG. 2 device with a USB Isolation Chip ADUM4160 product from Analog Devices, Inc. of Norwood, Massachusetts, USA
- the connector power element 210 is implemented in the FIG. 2 device with a USB Power Isolation Chip LT3573 product from Linear Technology Corporation of Milpitas, California, USA.
- Those skilled in the art will be aware of alternative suitable devices.
- a control processor 218 is connected to the system bus 212 and receives the data communications from the connector data element 208 for processing.
- the control processor controls operation of the various elements of the portable device 100 that are connected to the system bus.
- the control processor operates according to mode instructions that may be stored in device memory 220.
- the portable device 100 operates under control of the processor 218 so as to include at least two modes of operation, comprising an active mode and a safe mode.
- the active mode is an operating mode in which multiple device components are operated.
- the safe mode is an operating mode in which at least one device component is deactivated and is not operated. For example, in the active mode, the touchscreen display 122 and the pump 226 may be operated, whereas, in the safe mode, the pump may be deactivated and not operated.
- FIG. 3 is a flowchart that illustrates operation of the device.
- the processor operates the device in the active mode, in which a user may enter input at the input interface of the device.
- a user input is received at the input interface.
- the user input may comprise an intentional input at the device, such as a user interaction with the touchscreen, or the user input may comprise an accidental interaction with the touchscreen.
- the user input may optionally comprise making an affirmative action to place the device into safe mode.
- the affirmative action may comprise pressing a physical button or switch on the device or on a smart phone that turns off the display. This option useful, for example, for placing the device in the safe mode prior to placing the device in a pocket or purse.
- the device processor determines if the received user input was at an out of bounds region of the display.
- predetermined areas of the display screen will comprise an active area and other predetermined areas will comprise an out of bounds region.
- FIG. 4, 5, and 6 illustrate display screens with the respective predetermined out of bounds regions indicated.
- FIG. 4 shows a home screen display 402 with two rectangular out-of-bounds regions 404, 406 identified.
- FIG. 5 shows a data entry screen display 502 with two out-of-bounds regions 504, 506 identified.
- FIG. 6 shows confirmation screen display 602 with a relatively large rectangular out-of-bounds region 604 identified. Any single button input or predetermined plurality of inputs received in any of the out-of-bounds regions during a respective active operation while the corresponding screen is displayed will result in the device entering the safe mode.
- the processor proceeds to the operation of box 308, terminating the active mode of operation and initiating operation of the device in the safe mode. If the input was not received from an out of bounds region, a negative outcome at box 308, then the device continues to operate in the active mode and additional input may be received, as indicated by the return to operation at box 302.
- the processor will deactivate at least one component of the device while in the safe mode of operation. For example, the processor may deactivate the pump of the device while it is in the safe mode, to ensure that no accidental delivery of insulin is initiated.
- the processor may disable changes to settings in memory, to ensure that bolus settings and the like are not changed during the safe mode.
- the processor While in the safe mode of operation, the processor waits for an input comprising an activation input. If an activation input is received, an affirmative outcome at box 310, then the process terminates the safe mode of operation. Typically, the processor will return to the active mode of operation, but other modes may be initiated, as desired. For example, a power saving mode might be preferred. If no activation input is received, a negative outcome at box 310, then the processor maintains the device in the safe mode.
- the activation input may comprise selection of a wake display button or icon of the user interface.
- the activation input may comprise predetermined sequence of selected buttons or icons of the user interface.
- the sequence may comprise discrete selection of predetermined buttons on the touchscreen display.
- the predetermined sequence may comprise a sequence of predetermined button selections separated by predetermined amounts of time.
- the predetermined sequence may involve button selections that are separated in time by no more than an activation time value.
- the activation time value may have a value of, for example, no more than two seconds. If the time elapsed between any two display button selections is greater than two seconds, then the processor will consider the inputs to be random or accidental, and the processor will remain in the safe mode.
- the activation input can comprise a user swiping a touchscreen in a predetermined pattern or shape.
- FIG. 7 shows an example of an unlock screen 702 that is displayed on the touchscreen of the device as part of the safe mode operation. That is, when the device enters the safe mode, the processor produces an unlock screen display and awaits the activation input from that screen.
- the three buttons labeled "1", "2", and "3" must be pressed in proper (numerical) sequence, separated in time by no more than an activation time value.
- the safe mode can also be entered at the end of one or more predetermined sequences of user interaction with the pump, such as a sequence after which a user is likely to be finished interacting with a pump for a period of time.
- the pump can automatically enter a safe mode in which the screen is locked. This would prevent the user from inadvertently cancelling or modifying the bolus or otherwise interacting with the device in an unintended fashion during the bolus delivery while, for example, placing the pump back against the user's body. Pump operation can therefore subsequently be modified during delivery of the bolus only by unlocking the screen as described above.
- the pump can remain locked after the bolus is delivered and until the screen is unlocked.
- the device can also include any portable device having a display and a processor.
- the device can include a mobile computing device, such as a Smartphone.
- a mobile computing device can be used as a remote control to wirelessly control operations of medical devices as disclosed herein.
- medical devices as disclosed herein can be controlled remotely with a dedicated remote control specifically designed for use with the medical device.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Human Computer Interaction (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Input From Keyboards Or The Like (AREA)
Abstract
A portable medical device is operated in an active mode in which the device receives a user input at an input interface and provides the received user input to a processor of the device. The active mode is terminated and the device is operated in a safe mode, in which the received user input is not provided to the processor and/or one or more device function is disabled, in response to determining that the received user input was received in an out of bounds region of the input interface. The safe mode is terminated in response to receiving a predetermined user input comprising an activation input.
Description
PREVENTING INADVERTENT CHANGES IN AMBULATORY
MEDICAL DEVICES
RELATED APPLICATION
The present application claims the benefit of U.S. Provisional Application No.
61/656,997 filed June 7, 2012, and U.S. Utility Application No. 13/801,230 filed March 13, 2013, which are incorporated herein in their entireties by reference.
BACKGROUND
Portable ambulatory medical devices have proved useful for treating patients with medical conditions that require continuous monitoring and/or treatment. One example of such a portable ambulatory medical device is a device that involves the delivery of fluids. There are many applications in academic, industrial, and medical fields, as well as others, that involve devices capable of accurately and controllably delivering fluids, including liquids and gases, that have a beneficial effect when administered in known and controlled quantities. This is particularly true in the medical field, where treatments for many of patients include the administration of a known amount of a substance at predetermined intervals. For example, the treatment of diabetes involves just such a regimented dosage of medicaments such as insulin. In addition, diabetes is one of a few medical indications wherein patients routinely administer the medicament to themselves by a subcutaneous modality, such as a hypodermic syringe injection or by an ambulatory infusion pump. As such, providing a patient with the means to safely, reliably, and comfortably administer required doses of medication such as, e.g., insulin, may be particularly important in order to facilitate patient compliance and accurate treatment of the condition.
Ambulatory insulin infusion pumps have been developed for the administration of insulin for those diagnosed with both type I and type II diabetes. Ambulatory insulin pumps are medical infusion devices used for the administration of insulin in the treatment of diabetes, and offer an alternative to multiple daily injections of insulin by an insulin syringe or an insulin pen. They also allow for continuous insulin therapy. In addition, some ambulatory insulin infusion devices can include data collection and storage mechanisms, which allow a diabetic person and/or a doctor to easily monitor and adjust insulin intake. The infusion device may be powered by a rechargeable battery that requires periodic recharging.
Some ambulatory medical devices include a touchscreen on which symbols may be displayed and from which inputs may be received for operation of the device. Other input mechanisms involve keyboards or hardware switches. In general, a series of display screens or
windows are shown on a device display or on the device touchscreen, showing alphanumeric text and symbols, and providing menu screens through which the user can control operation of the device. User interaction, such as by touching the alphanumeric text and symbols, provides user input and facilitates navigation through the menu screens and selection of the device functions.
The phenomenon of unintended, inadvertent activation of portable devices is not an uncommon occurrence. Telephone calls accidentally placed via a mobile telephone through inadvertent activation have become a fact of modern life. Such accidental calls can be annoying and troublesome for a mobile telephone. In the case of a portable ambulatory medical device, such accidental activation can have serious consequences. In fact, in the case of portable ambulatory medical devices, any changes at all that are unintended or inadvertent may be problematic and even dangerous. For example, an untimely delivery of insulin, or delivery of an unexpectedly changed amount of insulin, or the absence of an expected dose, can have extremely deleterious results, and may even be dangerous to the user. User safety would be improved with a reduction in the likelihood of an accidental or unintended activation or deactivation of a portable ambulatory medical device.
SUMMARY
Disclosed herein are portable ambulatory medical devices and methods of operation that provide a reduced likelihood of inadvertent change in device operation. A device includes an active mode in which the device receives a user input at an input interface of the device and provides the received user input to a processor of the device. The active mode can be terminated and the device operated in a safe mode, in which the received user input is not provided to the processor and/or one or more device function is disabled, in response to determining that the received user input was received in an out of bounds region of the input interface. The safe mode is terminated in response to receiving a predetermined user input comprising an activation input. In some embodiments, the activation input can comprise selection of a wake display button or icon of the user interface, or may comprise a predetermined sequence of selected buttons or icons of the user interface.
In one embodiment, the activation input may be modified to require a timed pattern to wake the touchscreen. The pattern would require two or more presses that would be delivered in specified time windows, and if presses where detected outside of these windows, the sequence would be aborted.
In some embodiments, the portable device may include a user interface with control features such as buttons, switches or icons to control pumping and other functions, and the
portable device may include a touchscreen on which are displayed alphanumeric text, symbols, menu screens, data, alerts, and other information. The device may show one or more screens or windows on the touchscreen through which device control inputs are received. For each device screen display, one or more regions of the display, and/or one or more buttons or switches, will be considered out of bounds for any intended control input. During an active mode of the device, when control inputs are received, any user interaction with an out of bounds region can cause the active mode to be suspended and the device will be in a safe mode of operation in which at least one of the device components is not operated. The device will remain in the safe mode until it receives an activation input before permitting continued active operation. The activation input may comprise a sequence of multiple inputs from the user via the touchscreen or a group of multiple inputs provided simultaneously, such as multiple simultaneous button presses. Failure to receive the activation input will result in the device remaining in the safe mode. The activation input may require the user to comply with activation sequence parameters as to both multiple symbol interactions and time between the multiple interactions. Requiring the predetermined activation sequence before resuming normal operation reduces the likelihood of accidental or unintended activation of the portable ambulatory medical device and improves user safety.
Other features and advantages of the present invention should be apparent from the following description of preferred embodiments that illustrate, by way of example, the principles of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 depicts a portable device according to an embodiment of the present invention that is coupled to a patient for infusing medication thereto.
FIG. 2 is a block diagram of circuitry and components for the portable medical device illustrated in FIG. 1.
FIG. 3 is a flow diagram showing operations of the device in FIG. 1.
FIG. 4 depicts a display screen with a home screen display showing out-of-bounds regions according to an embodiment of the present invention.
FIG. 5 depicts a display screen with a data entry screen display showing out-of-bounds regions according to an embodiment of the present invention.
FIG. 6 depicts a display screen with a confirmation screen display showing an out-of- bounds region according to an embodiment of the present invention.
FIG. 7 depicts a display screen with an unlock screen display.
The drawings illustrate embodiments of the technology and are not limiting. For clarity and ease of illustration, the drawings may not be made to scale and, in some instances, various aspects may be shown exaggerated or enlarged to facilitate an understanding of particular embodiments.
DETAILED DESCRIPTION
Disclosed herein are embodiments directed to a portable medical device having an interactive display screen, such as a touch screen, for control by the user, and having a connecting tube with an infusion port for administering medication to a patient.
FIG. 1 shows an electrically-powered portable device 100 that is coupled to a host power source 102, such as a desktop or laptop computer, through a cable 104. The cable may comprise, for example, a coupling through which both data and electrical energy are received at the portable device 100. Examples of such combined power and data cables include a Universal Serial Bus (USB) connection, an IEEE 1499 connection, a "THUNDERBOLT" connection (i.e., from Apple, Inc., of Cupertino, CA, USA), PCI Express, eSATA and Ethernet. The host power source 102 is a source of electrical energy and can be any type of computing device that includes a port 106 that receives a connector 108 of the cable 104. The port of the host computing device may comprise, for example, a USB port, or IEEE 1499 port, or port for THUNDERBOLT, PCI Express, eSATA or Ethernet. A compatible connector port 110 of the portable device 100 is coupled to the cable 104 at an opposite end 112 of the cable. In a USB implementation, for example, the cable 104 is a USB cable and associated connections and ports may support one or more of USB version 1.1 , 2.0, or 3.0 data transfer speeds.
The portable device 100 may be coupled to a patient 114 via an infusion port 116 and a connecting tube or cannula 118. The connecting tube is coupled to the portable device 100 at a fluid dispending port 120. The portable device may include control features, such as buttons or switches 121 to receive user input and control pumping and other features, and may include a display screen 122 on which are displayed messages and alerts. The display 122 may comprise, for example, a touchscreen on which user inputs may be received. A housing 124 of the portable device encloses internal components, such as fluid reservoirs, electrical components, battery, and the like. The portable device 100 illustrated in FIG. 1 comprises a portable medical device of the type worn by a patient 114 such that insulin fluid is delivered via the connecting tube 118 and the fluid dispensing port 120 by a delivery mechanism. Exemplary ambulatory medical devices and features include those, e.g., disclosed in U.S. Patent Application No. 13/557,163, U.S. Patent Application No. 12/714,299, U.S. Patent Application No. 12/538,018, U.S. Provisional Patent
Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Patent No. 8,287,495. Each of the aforementioned documents is hereby incorporated herein by reference in its entirety.
The portable device 100 can be coupled to a host power source such as a desktop or laptop computer, through a cable connected to the connector port 110. The cable may comprise, for example, a coupling through which both data and electrical energy are received at the portable device 100. Examples of such combined power and data cables include a Universal Serial Bus (USB) connection, an IEEE 1499 (Fire Wire) connection, a "THUNDERBOLT" connection (from Apple, Inc. of Cupertino, CA, USA), PCI Express, eSATA and Ethernet.
The device 100 may also include a capability to operatively couple to one or more other devices via a wired or wireless (e.g., infrared, electronic, optical, etc.) link, locally or via a network, such as, e.g., a portable or non-portable medical device, a control unit, external monitor or display, a personal laptop, tablet or mainframe computer, or mobile communication device such as a smartphone or personal digital assistant (PDA). Such other devices may control or be controlled by device 100 and/or may otherwise communicate for the transfer of data including device parameters between or among device 100 and other device(s) for analysis of data (e.g., user data for physician review, device diagnostic data for troubleshooting or repair), programming, or other uses.
The portable device 100 may include control features such as buttons, panels, screens, and/or switches to control the device, or any combination of such control features. For example, the portable device 100 illustrated in Fig. 1 shows a touchscreen 122 on which can be displayed alphanumeric text, symbols, menu screens, data, alerts and the like for receiving control input. The portable device may include a processor with memory, wherein the processor executes program instructions to provide an operating system that supports programs that execute and provide the specified features. The touchscreen 122 may be interactive, wherein user input may be received such as by pressing the outer surface of the touchscreen. The touchscreen 122 may be configured to display menu screens or pages that allow the user to input data fields, e.g., select device parameters, so as to allow the program to produce a suggested delivery amount, rate, profile, and/or the like in an intuitive, manipulable, and/or graphic representation, thereby allowing the user to interact with the screen to shape the characteristic/form of the delivery amount, rate, and/or graphic delivery profile, e.g., by manipulating the delivery estimate or pattern displayed on the screen to effectuate the actual delivery.
Device parameters provided by the portable infusion device may be presented on the display screen 122 as any number of objects, including one or more numeric and/or
alphanumeric values, a range, a value or range that is presented in the form of a drop-down menu, a toggle that can be adjusted by the user, a graphical representation (e.g., icon) or an animated graphic. For instance, in certain embodiments, the value is a range of values that are presented on a screen of the display as a toggle, wherein the toggle may be adjusted upwards or downwards by the user swiping a finger over the screen to select the appropriate value range, e.g. appropriate range of amounts of medicament such as insulin to be delivered and/or the appropriate rate, time, or interval of medicament delivery. In certain instances, the values presented in the range may be adjusted by the processor (illustrated in FIG. 2). Other device parameters will be readily apparent to those skilled in the art.
The type of touch screen 122 may vary as desired to be useful for a particular application, such as LCD displays, LED displays, plasma displays, organic LED (OLED) displays, and the like. The touchscreen 122 may be implemented with a capacitance screen, a resistive screen, or other such display/input technology. The portable device 100 may additionally include a keyboard or other input device known in the art for data entry, which may be separate from the display.
FIG. 2 shows a block diagram of some of the components within the portable device 100 of FIG. 1. The portable device 100 includes a power management system 202 that is connected to the connector port 110 that receives a combined data/power cable, such as the USB cable 104 illustrated in FIG. 1. That is, the cable 104 has the capability of simultaneously providing electrical energy for charging and data transmission for communications. A connector interface 206 supports data exchange and receives electrical power through the connector port 110, and controls a connector data element 208 and a connector power element 210. The device may be powered by battery power in place of or in addition to the connector interface. The connector interface 206 passes data communications from the connector port 110 through the connector data element 208 to a system bus 212. The connector interface 206 passes electrical power from the connector port 110 through the connector power element 210 to a battery charger 214, which in turn is coupled to a battery 216 and which recharges the battery. In one embodiment, he connector data element 208 is implemented in the FIG. 2 device with a USB Isolation Chip ADUM4160 product from Analog Devices, Inc. of Norwood, Massachusetts, USA, and the connector power element 210 is implemented in the FIG. 2 device with a USB Power Isolation Chip LT3573 product from Linear Technology Corporation of Milpitas, California, USA. Those skilled in the art will be aware of alternative suitable devices.
A control processor 218 is connected to the system bus 212 and receives the data communications from the connector data element 208 for processing. The control processor
controls operation of the various elements of the portable device 100 that are connected to the system bus. The control processor operates according to mode instructions that may be stored in device memory 220.
The portable device 100 operates under control of the processor 218 so as to include at least two modes of operation, comprising an active mode and a safe mode. The active mode is an operating mode in which multiple device components are operated. The safe mode is an operating mode in which at least one device component is deactivated and is not operated. For example, in the active mode, the touchscreen display 122 and the pump 226 may be operated, whereas, in the safe mode, the pump may be deactivated and not operated.
FIG. 3 is a flowchart that illustrates operation of the device. In the first operation, indicated by the flowchart box 302, the processor operates the device in the active mode, in which a user may enter input at the input interface of the device. At the next operation, at box 304, a user input is received at the input interface. The user input may comprise an intentional input at the device, such as a user interaction with the touchscreen, or the user input may comprise an accidental interaction with the touchscreen. The user input may optionally comprise making an affirmative action to place the device into safe mode. For example, the affirmative action may comprise pressing a physical button or switch on the device or on a smart phone that turns off the display. This option useful, for example, for placing the device in the safe mode prior to placing the device in a pocket or purse. In the next operation, indicated by the decision box 306, the device processor determines if the received user input was at an out of bounds region of the display. For each display screen during operation of the device, predetermined areas of the display screen will comprise an active area and other predetermined areas will comprise an out of bounds region. For example, FIG. 4, 5, and 6 illustrate display screens with the respective predetermined out of bounds regions indicated. FIG. 4 shows a home screen display 402 with two rectangular out-of-bounds regions 404, 406 identified. FIG. 5 shows a data entry screen display 502 with two out-of-bounds regions 504, 506 identified. FIG. 6 shows confirmation screen display 602 with a relatively large rectangular out-of-bounds region 604 identified. Any single button input or predetermined plurality of inputs received in any of the out-of-bounds regions during a respective active operation while the corresponding screen is displayed will result in the device entering the safe mode.
Returning to the flow diagram of FIG. 3, if the input was at an out-of-bounds region, an affirmative outcome at box 306, then the processor proceeds to the operation of box 308, terminating the active mode of operation and initiating operation of the device in the safe mode. If the input was not received from an out of bounds region, a negative outcome at box 308, then
the device continues to operate in the active mode and additional input may be received, as indicated by the return to operation at box 302. The processor will deactivate at least one component of the device while in the safe mode of operation. For example, the processor may deactivate the pump of the device while it is in the safe mode, to ensure that no accidental delivery of insulin is initiated. The processor may disable changes to settings in memory, to ensure that bolus settings and the like are not changed during the safe mode.
While in the safe mode of operation, the processor waits for an input comprising an activation input. If an activation input is received, an affirmative outcome at box 310, then the process terminates the safe mode of operation. Typically, the processor will return to the active mode of operation, but other modes may be initiated, as desired. For example, a power saving mode might be preferred. If no activation input is received, a negative outcome at box 310, then the processor maintains the device in the safe mode.
The activation input may comprise selection of a wake display button or icon of the user interface. Alternatively, the activation input may comprise predetermined sequence of selected buttons or icons of the user interface. For example, the sequence may comprise discrete selection of predetermined buttons on the touchscreen display. In another alternative, the predetermined sequence may comprise a sequence of predetermined button selections separated by predetermined amounts of time. For example, the predetermined sequence may involve button selections that are separated in time by no more than an activation time value. The activation time value may have a value of, for example, no more than two seconds. If the time elapsed between any two display button selections is greater than two seconds, then the processor will consider the inputs to be random or accidental, and the processor will remain in the safe mode. In a further embodiment, the activation input can comprise a user swiping a touchscreen in a predetermined pattern or shape.
FIG. 7 shows an example of an unlock screen 702 that is displayed on the touchscreen of the device as part of the safe mode operation. That is, when the device enters the safe mode, the processor produces an unlock screen display and awaits the activation input from that screen. For example, in FIG. 7, the three buttons labeled "1", "2", and "3" must be pressed in proper (numerical) sequence, separated in time by no more than an activation time value.
In some embodiments, the safe mode can also be entered at the end of one or more predetermined sequences of user interaction with the pump, such as a sequence after which a user is likely to be finished interacting with a pump for a period of time. For example, after a user programs a bolus and executes a deliver command, the pump can automatically enter a safe mode in which the screen is locked. This would prevent the user from inadvertently cancelling
or modifying the bolus or otherwise interacting with the device in an unintended fashion during the bolus delivery while, for example, placing the pump back against the user's body. Pump operation can therefore subsequently be modified during delivery of the bolus only by unlocking the screen as described above. In one embodiment, the pump can remain locked after the bolus is delivered and until the screen is unlocked.
Although the aforementioned description specifically describes a portable medical device for administering insulin to a patient, it should be understood that such a device is only one embodiment of the invention. The device can also include any portable device having a display and a processor. For example, the device can include a mobile computing device, such as a Smartphone. In one embodiment, such a mobile computing device can be used as a remote control to wirelessly control operations of medical devices as disclosed herein. Alternatively, medical devices as disclosed herein can be controlled remotely with a dedicated remote control specifically designed for use with the medical device.
The methods, systems, and devices discussed above are intended merely to be examples. Various embodiments may omit, substitute, or add various procedures or components as appropriate. For example, it should be appreciated that, in alternative embodiments, the methods may be performed in an order different from that described, and various steps may be added, omitted, or combined. Also, features described with respect to certain embodiments may be combined in various other embodiments. Different aspects and elements of the embodiments may be combined in a similar manner. Also, it should be emphasized that technology evolves and, thus, many of the elements are examples and should not be interpreted to limit the scope of the invention.
Specific details are given in this description to provide a thorough understanding of the embodiments. Nevertheless, it will be understood by one of ordinary skill in the art that the embodiments may be practiced without these specific details. For example, well-known circuits, processes, algorithms, structures, and techniques have been shown without unnecessary detail in order to avoid obscuring the embodiments. Further, the headings provided herein are intended merely to aid in the clarity of the descriptions of various embodiments, and should not be construed as limiting the scope of the invention or the functionality of any part of the invention. For example, certain methods or components may be implemented as part of other methods or components, even though they are described under different headings.
It is noted that embodiments may have been described as a process that is depicted as a flow diagram or block diagram. Although each diagram may describe the process as a sequential series of operations, many of the operations can be performed in parallel or concurrently. In
addition, the order of the operations may be rearranged. A process may have additional steps not included in the figures. Each operation of a process is performed or executed by the processor of the device.
The description above has been provided in terms of presently preferred embodiments so that an understanding of the present invention can be conveyed. There are, however, many configurations and techniques for data management systems that were not specifically described herein, but with which the present invention is applicable. The present invention should therefore not be seen as limited to the particular embodiments described herein, but rather, it should be understood that the present invention has wide applicability with respect to data management generally. All modifications, variations, or equivalent arrangements and implementations that are within the scope of the attached claims should therefore be considered within the scope of the invention.
Claims
1. An ambulatory infusion system, comprising:
a housing;
a delivery mechanism at least partially contained within the housing and adapted to facilitate delivery of fluid to a user;
a user interface comprising a touchscreen, the touchscreen adapted to display a plurality of input screens and receive touch input from a user on the input screens;
a memory adapted to store operating parameters and settings relating to use of the delivery mechanism; and
a processor disposed in the housing and configured to control operation of the system in an active mode and a safe mode, wherein in the safe mode the processor disables at least one system function that is active in the active mode, the processor further configured to:
define at least one out of bounds region on at least one of the input screens and associate the out of bounds regions with the corresponding input screen in the memory; identify a touch input on the touchscreen on the at least one of the input screens that is in at least one of the out of bounds regions associated with the input screen while the operation of the pump is in the active mode;
suspend operation of the system in the active mode and place operation of the system in the safe mode in response to the out of bounds touch input.
2. The ambulatory infusion pump of claim 1, wherein the processor is further configured to terminate the safe mode and return to the active mode upon identifying a touch input at the touchscreen as a predetermined activation input.
3. The ambulatory infusion pump of claim 2, wherein the predetermined activation input comprises selection of a wake display icon on the user interface.
4. The ambulatory infusion pump of claim 2, wherein the predetermined activation input comprises a predetermined sequence of selected icons on the user interface.
5. The ambulatory infusion pump of claim 5, wherein the predetermined sequence comprises a series of distinct touch inputs each separated by no more than a maximum predetermined amount of time.
6. The ambulatory infusion pump of claim 1, wherein the processor is further configured to display an unlock screen on the touchscreen after safe mode is entered.
7. The ambulatory infusion pump of claim 1, wherein the processor defines at least one out of bounds region for a plurality of input screens, each out of bounds region customized for the specific input screen.
8. The ambulatory infusion pump of claim 1, wherein the at least one function that is disabled in the safe mode is operation of the delivery mechanism.
9. The ambulatory infusion pump of claim 1, wherein the at least one function that is disabled in the safe mode is alteration of the operating parameters and setting stored in the memory.
10. The ambulatory infusion pump of claim 1, wherein the touchscreen is disposed on the housing.
11. The ambulatory infusion pump of claim 1, wherein the touchscreen is disposed on a separate device remote from the housing and the processor is adapted to receive information related to the touch input on the touchscreen wirelessly from the separate device.
12. An ambulatory infusion pump, comprising:
a processor that controls operation of the pump in a plurality of operating modes that include an active mode in which multiple pump components are operated and a safe mode in which at least one pump component is deactivated and not operated;
an input interface through which the processor receives user input; and
wherein the processor terminates the active mode and operates the pump in the safe mode in response to determining that a received user input was received in an out of bounds region of the input interface.
13. The ambulatory infusion pump of claim 12, wherein the processor terminates the safe mode in response to receiving an activation user input through the input interface comprising a predetermined activation input.
14. The ambulatory infusion pump of claim 13, wherein the activation input comprises selection of a wake display icon of the input interface.
15. The ambulatory infusion pump of claim 13, wherein the activation input comprises a predetermined sequence of selected icons on the input interface.
16. The ambulatory infusion pump of claim 15, wherein the predetermined sequence comprises a series of distinct inputs each separated by no more than a maximum predetermined amount of time.
17. The ambulatory infusion pump of claim 13, wherein the processor resumes operating the device in the active mode in response to terminating the safe mode.
18. The ambulatory infusion pump of claim 12, wherein the processor is further configured to display an unlock screen on the input interface after safe mode is entered.
19. The ambulatory infusion pump of claim 12, wherein the at least one pump component that is deactivated in the safe mode is a delivery mechanism for delivering fluid to a user.
20. The ambulatory infusion pump of claim 12, wherein the at least one pump component that is deactivated in the safe mode is a memory for storing alteration of operating parameters and setting.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13800236.5A EP2858697B1 (en) | 2012-06-07 | 2013-06-05 | Preventing inadvertent changes in ambulatory medical devices |
EP19186132.7A EP3584797A3 (en) | 2012-06-07 | 2013-06-05 | Preventing inadvertent changes in ambulatory medical devices |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656997P | 2012-06-07 | 2012-06-07 | |
US61/656,997 | 2012-06-07 | ||
US13/801,230 | 2013-03-13 | ||
US13/801,230 US9715327B2 (en) | 2012-06-07 | 2013-03-13 | Preventing inadvertent changes in ambulatory medical devices |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013184812A1 true WO2013184812A1 (en) | 2013-12-12 |
Family
ID=49712595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/044329 WO2013184812A1 (en) | 2012-06-07 | 2013-06-05 | Preventing inadvertent changes in ambulatory medical devices |
Country Status (3)
Country | Link |
---|---|
US (3) | US9715327B2 (en) |
EP (2) | EP2858697B1 (en) |
WO (1) | WO2013184812A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108134950A (en) * | 2017-12-07 | 2018-06-08 | 上海斐讯数据通信技术有限公司 | A kind of intelligent video recommends method and system |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8149131B2 (en) | 2006-08-03 | 2012-04-03 | Smiths Medical Asd, Inc. | Interface for medical infusion pump |
US9029157B2 (en) * | 2007-04-12 | 2015-05-12 | Nipro Diagnostics, Inc. | Error detection and rejection for a diagnostic testing system |
US8133197B2 (en) | 2008-05-02 | 2012-03-13 | Smiths Medical Asd, Inc. | Display for pump |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
US8758323B2 (en) | 2009-07-30 | 2014-06-24 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9335910B2 (en) | 2012-04-23 | 2016-05-10 | Tandem Diabetes Care, Inc. | System and method for reduction of inadvertent activation of medical device during manipulation |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
US9715327B2 (en) | 2012-06-07 | 2017-07-25 | Tandem Diabetes Care, Inc. | Preventing inadvertent changes in ambulatory medical devices |
US9258350B2 (en) | 2012-10-01 | 2016-02-09 | Dexcom, Inc. | Analyte data retriever |
US10357606B2 (en) | 2013-03-13 | 2019-07-23 | Tandem Diabetes Care, Inc. | System and method for integration of insulin pumps and continuous glucose monitoring |
US9940441B2 (en) | 2013-03-13 | 2018-04-10 | Tandem Diabetes Care, Inc. | System and method for maximum insulin pump bolus override |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US9242043B2 (en) | 2013-03-15 | 2016-01-26 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
USD731520S1 (en) * | 2013-06-20 | 2015-06-09 | Tencent Technology (Shenzhen) Company Limited | Portion of a display screen with animated graphical user interface |
USD734356S1 (en) * | 2013-06-20 | 2015-07-14 | Tencent Technology (Shenzhen) Company Limited | Portion of a display screen with animated graphical user interface |
MX2016005252A (en) | 2013-10-24 | 2016-10-07 | Univ Boston | Infusion system for preventing mischanneling of multiple medicaments. |
EP3086828B1 (en) | 2013-12-26 | 2023-08-09 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
EP3087548A4 (en) | 2013-12-26 | 2017-09-13 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
EP3100189A1 (en) * | 2014-01-28 | 2016-12-07 | Debiotech S.A. | Control device with recommendations |
USD760272S1 (en) * | 2014-04-30 | 2016-06-28 | Tencent Technology (Shenzhen) Company Limited | Portion of a display screen with graphical user interface |
US10279106B1 (en) | 2014-05-08 | 2019-05-07 | Tandem Diabetes Care, Inc. | Insulin patch pump |
CA2949846C (en) | 2014-06-03 | 2023-09-05 | Amgen Inc. | Devices and methods for assisting a user of a drug delivery device |
JP6678654B2 (en) * | 2014-09-10 | 2020-04-08 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Actuation systems and methods for on-body medical devices |
US11357916B2 (en) | 2014-12-19 | 2022-06-14 | Amgen Inc. | Drug delivery device with live button or user interface field |
WO2016100781A1 (en) | 2014-12-19 | 2016-06-23 | Amgen Inc. | Drug delivery device with proximity sensor |
JP7125204B2 (en) | 2015-07-08 | 2022-08-24 | トラスティーズ オブ ボストン ユニバーシティ | Infusion system and its components |
CN112657013B (en) | 2015-08-20 | 2023-10-03 | 坦德姆糖尿病护理股份有限公司 | Driving mechanism for perfusion pump |
US10492141B2 (en) * | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
EP3402551A4 (en) * | 2016-01-12 | 2019-10-23 | Infusion Innovations Pty Ltd | Infusion device |
EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
CN113101448B (en) | 2016-01-14 | 2024-01-23 | 比格福特生物医药公司 | System for adjusting insulin delivery rate |
US11593342B2 (en) | 2016-02-01 | 2023-02-28 | Smartshift Technologies, Inc. | Systems and methods for database orientation transformation |
US10585655B2 (en) | 2016-05-25 | 2020-03-10 | Smartshift Technologies, Inc. | Systems and methods for automated retrofitting of customized code objects |
US10994077B2 (en) * | 2016-07-21 | 2021-05-04 | Tandem Diabetes Care, Inc. | Enhanced confirmations for touchscreen infusion pump |
US10089103B2 (en) | 2016-08-03 | 2018-10-02 | Smartshift Technologies, Inc. | Systems and methods for transformation of reporting schema |
IL267822B2 (en) | 2017-01-06 | 2023-09-01 | Univ Boston | Infusion system and components thereof |
EP3568859A1 (en) | 2017-01-13 | 2019-11-20 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
USD825584S1 (en) | 2017-03-29 | 2018-08-14 | Becton, Dickinson And Company | Display screen or portion thereof with transitional graphical user interface |
US11166503B2 (en) * | 2017-04-17 | 2021-11-09 | Interactive Skin, Inc. | Interactive skin for wearable |
USD826956S1 (en) * | 2017-06-08 | 2018-08-28 | Insulet Corporation | Display screen with a graphical user interface |
JP7279023B2 (en) | 2017-09-12 | 2023-05-22 | スミスズ メディカル エーエスディー,インコーポレイティド | User experience for infusion pumps |
US10698674B2 (en) | 2018-02-06 | 2020-06-30 | Smartshift Technologies, Inc. | Systems and methods for entry point-based code analysis and transformation |
US10528343B2 (en) | 2018-02-06 | 2020-01-07 | Smartshift Technologies, Inc. | Systems and methods for code analysis heat map interfaces |
US10740075B2 (en) * | 2018-02-06 | 2020-08-11 | Smartshift Technologies, Inc. | Systems and methods for code clustering analysis and transformation |
USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US11864899B2 (en) | 2018-04-18 | 2024-01-09 | Interactive Skin, Inc. | Interactive skin |
USD875766S1 (en) | 2018-08-10 | 2020-02-18 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD875765S1 (en) | 2018-08-10 | 2020-02-18 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD864218S1 (en) | 2018-08-20 | 2019-10-22 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD864217S1 (en) | 2018-08-20 | 2019-10-22 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD880496S1 (en) | 2018-08-20 | 2020-04-07 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD864219S1 (en) | 2018-08-20 | 2019-10-22 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD882622S1 (en) | 2018-08-22 | 2020-04-28 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD875767S1 (en) | 2018-08-23 | 2020-02-18 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
US10736037B2 (en) | 2018-12-26 | 2020-08-04 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
WO2020171838A1 (en) | 2019-02-19 | 2020-08-27 | Tandem Diabetes Care, Inc. | System and method of pairing an infusion pump with a remote control device |
EP3946514A4 (en) | 2019-03-26 | 2022-12-21 | Tandem Diabetes Care, Inc. | Method of pairing an infusion pump with a remote control device |
US20200368430A1 (en) | 2019-05-21 | 2020-11-26 | Tandem Diabetes Care, Inc. | System and method for incorporating exercise into closed-loop diabetes therapy |
MX2022000668A (en) | 2019-07-16 | 2022-05-20 | Beta Bionics Inc | Ambulatory device and components thereof. |
CA3146872A1 (en) | 2019-07-16 | 2021-01-21 | Beta Bionics, Inc. | Blood glucose control system |
USD931306S1 (en) | 2020-01-20 | 2021-09-21 | Tandem Diabetes Care, Inc. | Display screen or portion thereof with graphical user interface |
USD1031975S1 (en) | 2020-03-10 | 2024-06-18 | Beta Bionics, Inc. | Medicament infusion pump device |
USD1032624S1 (en) | 2020-03-10 | 2024-06-25 | Beta Bionics, Inc. | Display screen with animated graphical user interface |
US11278661B2 (en) | 2020-03-10 | 2022-03-22 | Beta Bionics, Inc. | Infusion system and components thereof |
TWD213149S (en) * | 2020-04-09 | 2021-08-11 | 仁寶電腦工業股份有限公司 | Graphical user interface for display screen |
USD977502S1 (en) | 2020-06-09 | 2023-02-07 | Insulet Corporation | Display screen with graphical user interface |
US11688501B2 (en) | 2020-12-07 | 2023-06-27 | Beta Bionics, Inc. | Ambulatory medicament pump with safe access control |
US20220199218A1 (en) | 2020-12-07 | 2022-06-23 | Beta Bionics, Inc. | Ambulatory medicament pump with integrated medicament ordering interface |
US20220265143A1 (en) | 2020-12-07 | 2022-08-25 | Beta Bionics, Inc. | Ambulatory medicament pumps with selective alarm muting |
US11830595B2 (en) | 2021-04-26 | 2023-11-28 | Tandem Diabetes Care, Inc. | Systems and methods for processing diabetes therapy data |
US11550445B1 (en) | 2021-07-06 | 2023-01-10 | Raytheon Company | Software safety-locked controls to prevent inadvertent selection of user interface elements |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024229A2 (en) * | 1994-03-09 | 1995-09-14 | Baxter International Inc. | Ambulatory infusion pump |
WO2000018449A2 (en) * | 1998-09-30 | 2000-04-06 | Minimed Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US20110047499A1 (en) * | 2008-04-01 | 2011-02-24 | Deka Products Limited Partnership | Infusion pump methods and systems |
US20120030610A1 (en) * | 2009-07-30 | 2012-02-02 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US20120109100A1 (en) * | 2007-09-06 | 2012-05-03 | Asante Solutions, Inc. | Operating A Portable Medical Device |
Family Cites Families (211)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935099A (en) | 1992-09-09 | 1999-08-10 | Sims Deltec, Inc. | Drug pump systems and methods |
US5338157B1 (en) | 1992-09-09 | 1999-11-02 | Sims Deltec Inc | Systems and methods for communicating with ambulat |
US6241704B1 (en) | 1901-11-22 | 2001-06-05 | Sims Deltec, Inc. | Drug pump systems and methods |
US4191184A (en) | 1977-01-06 | 1980-03-04 | Carlisle Jeffrey A | Intravenous infusion regulation system with reciprocal metering means |
US4810243A (en) | 1985-01-18 | 1989-03-07 | Intelligent Medicine, Inc. | Device and method for effecting application of a therapeutic agent |
US5247434A (en) | 1991-04-19 | 1993-09-21 | Althin Medical, Inc. | Method and apparatus for kidney dialysis |
US5486286A (en) | 1991-04-19 | 1996-01-23 | Althin Medical, Inc. | Apparatus for performing a self-test of kidney dialysis membrane |
US5207666A (en) | 1991-08-30 | 1993-05-04 | Infusaid, Inc. | Passive shuttle metering device for implantable drug delivery system |
JP3660678B2 (en) | 1992-10-15 | 2005-06-15 | ザ ゼネラル ホスピタル コーポレーション | Infusion pump with electronically loadable drug library |
EP0693924B2 (en) | 1993-02-22 | 2008-04-09 | Abraxis BioScience, Inc. | Methods for (in vivo) delivery of biologics and compositions useful therefor |
US5431626A (en) | 1993-03-03 | 1995-07-11 | Deka Products Limited Partnership | Liquid pumping mechanisms for peritoneal dialysis systems employing fluid pressure |
US5438510A (en) | 1993-03-03 | 1995-08-01 | Deka Products Limited Partnership | User interface and monitoring functions for automated peritoneal dialysis systems |
US5558638A (en) | 1993-04-30 | 1996-09-24 | Healthdyne, Inc. | Patient monitor and support system |
US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
GB9403021D0 (en) | 1994-02-17 | 1994-04-06 | Clinical Product Dev Ltd | Couplings for medical cannulae |
US5582593A (en) | 1994-07-21 | 1996-12-10 | Hultman; Barry W. | Ambulatory medication delivery system |
US5971593A (en) | 1994-12-16 | 1999-10-26 | Diebold, Incorporated | Dispensing system for medical items |
US5848593A (en) | 1994-12-16 | 1998-12-15 | Diebold, Incorporated | System for dispensing a kit of associated medical items |
US5685844A (en) | 1995-01-06 | 1997-11-11 | Abbott Laboratories | Medicinal fluid pump having multiple stored protocols |
US5707212A (en) | 1995-05-12 | 1998-01-13 | Matthews; Ernest L. | Apparatus for precisely controlling the feeding of viscous and non-viscous liquid products into a packaging machine |
US6018289A (en) | 1995-06-15 | 2000-01-25 | Sekura; Ronald D. | Prescription compliance device and method of using device |
US5964724A (en) | 1996-01-31 | 1999-10-12 | Medtronic Electromedics, Inc. | Apparatus and method for blood separation |
PT1238659E (en) | 1996-02-02 | 2005-01-31 | Alza Corp | SUSTAINED LIBERATION OF AN ACTIVE AGENT USING AN IMPLANTABLE SYSTEM |
US6395292B2 (en) | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US5782805A (en) | 1996-04-10 | 1998-07-21 | Meinzer; Randolph | Medical infusion pump |
DE19629093C2 (en) | 1996-07-18 | 2000-03-23 | Siemens Ag | Medical therapy and / or diagnostic system |
US6783328B2 (en) | 1996-09-30 | 2004-08-31 | Terumo Cardiovascular Systems Corporation | Method and apparatus for controlling fluid pumps |
US5915380A (en) * | 1997-03-14 | 1999-06-29 | Nellcor Puritan Bennett Incorporated | System and method for controlling the start up of a patient ventilator |
US6070761A (en) | 1997-08-22 | 2000-06-06 | Deka Products Limited Partnership | Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs |
DE19742637C5 (en) | 1997-09-26 | 2005-06-02 | Fresenius Medical Care Deutschland Gmbh | Device and method for operating medical devices |
US6056522A (en) | 1998-05-13 | 2000-05-02 | Sims Deltec, Inc. | Reusable cassette with a moveable door |
US6537272B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6126642A (en) | 1998-10-02 | 2000-10-03 | Science Incorporated | Patient controlled fluid delivery device |
US6635048B1 (en) | 1999-04-30 | 2003-10-21 | Medtronic, Inc. | Implantable medical pump with multi-layer back-up memory |
US7933780B2 (en) | 1999-10-22 | 2011-04-26 | Telaric, Llc | Method and apparatus for controlling an infusion pump or the like |
US8002700B2 (en) | 1999-12-30 | 2011-08-23 | Medtronic, Inc. | Communications system for an implantable medical device and a delivery device |
US6811534B2 (en) | 2000-01-21 | 2004-11-02 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
WO2003008014A2 (en) | 2000-01-21 | 2003-01-30 | Medical Research Group | Ambulatory medical apparatus with hand held communication device |
US7369635B2 (en) | 2000-01-21 | 2008-05-06 | Medtronic Minimed, Inc. | Rapid discrimination preambles and methods for using the same |
EP1604024A4 (en) | 2000-04-06 | 2008-04-23 | Wayne P Franco | Methods of using growth factors for treating heart disease |
US7166280B2 (en) | 2000-04-06 | 2007-01-23 | Franco Wayne P | Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease |
US6511435B1 (en) | 2000-04-14 | 2003-01-28 | Computerized Screening, Inc. | Blood pressure measurement system |
US9135393B1 (en) | 2000-08-02 | 2015-09-15 | Smiths Medical Asd, Inc. | Processing program data for medical pumps |
US7090648B2 (en) | 2000-09-28 | 2006-08-15 | Non-Invasive Monitoring Systems, Inc. | External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention |
US6874094B2 (en) | 2000-12-19 | 2005-03-29 | Microsoft Corporation | Method for locking user input elements for a small computer device by ignoring input signals if a locking signal is generated by a calendar-type application program |
US6425878B1 (en) | 2001-02-28 | 2002-07-30 | L.G.Med Ltd. | Method and device for detecting extravasation |
US7445616B2 (en) | 2001-03-23 | 2008-11-04 | Petrakis Dennis N | Temperature responsive systems |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US8034026B2 (en) | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
DK2574662T3 (en) | 2001-08-22 | 2021-09-20 | Maxcyte Inc | Method for electroporation of biological samples |
DE10142738C1 (en) * | 2001-08-24 | 2003-04-17 | Storz Endoskop Prod Gmbh | Device for operating a medical device, in particular a movable operating table |
US7204823B2 (en) | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
US8504179B2 (en) | 2002-02-28 | 2013-08-06 | Smiths Medical Asd, Inc. | Programmable medical infusion pump |
US6744350B2 (en) | 2002-02-28 | 2004-06-01 | Smiths Medical Md, Inc. | Insulin pump having missed meal bolus alarm |
US20080172026A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a suspension bolus |
US8250483B2 (en) | 2002-02-28 | 2012-08-21 | Smiths Medical Asd, Inc. | Programmable medical infusion pump displaying a banner |
US6852104B2 (en) | 2002-02-28 | 2005-02-08 | Smiths Medical Md, Inc. | Programmable insulin pump |
DE10235546A1 (en) * | 2002-03-25 | 2003-10-09 | Agere Syst Guardian Corp | Automatic keypad unlocking device for mobile telephones operated on the basis of several key inputs set to lock or unlock the keypad |
US7407473B2 (en) * | 2002-04-19 | 2008-08-05 | Thermo Fisher Scientific (Asheville) Llc | Centrifuge sleep mode control |
US7699767B2 (en) | 2002-07-31 | 2010-04-20 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US7118676B2 (en) | 2003-09-04 | 2006-10-10 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US7801596B2 (en) | 2002-09-20 | 2010-09-21 | Angel Medical Systems, Inc. | Physician's programmer for implantable devices having cardiac diagnostic and patient alerting capabilities |
US7390314B2 (en) | 2003-03-05 | 2008-06-24 | Medtronic Minimed, Inc. | Lead screw driven reservoir with integral plunger nut and method of using the same |
US7201730B2 (en) | 2003-03-17 | 2007-04-10 | Hemavation, Llc | Device and method for reducing inflammatory mediators in blood |
US7207964B2 (en) | 2003-03-17 | 2007-04-24 | Hemavation, Llc | Apparatus and method for down-regulating immune system mediators in blood |
AU2004232289A1 (en) | 2003-04-18 | 2004-11-04 | Insulet Corporation | User interface for infusion pump remote controller and method of using the same |
US6990809B2 (en) | 2003-06-16 | 2006-01-31 | Afif Abouraphael | Hydroelectric power plant designed to transform the potential energy of compressed gas into mechanical and electrical energy through the potential energy of liquids |
WO2005008403A2 (en) | 2003-07-10 | 2005-01-27 | Computer Associates Think, Inc. | Apparatuses and methods for dynamic creation of phase gantt charts |
WO2005007223A2 (en) | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
WO2005007075A2 (en) | 2003-07-21 | 2005-01-27 | Ai-Semi Ltd. | Adaptive resynchronization therapy system |
US20100168542A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7986986B2 (en) | 2003-08-01 | 2011-07-26 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7778680B2 (en) | 2003-08-01 | 2010-08-17 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7256888B2 (en) | 2003-11-07 | 2007-08-14 | Cardial Health 303, Inc. | Fluid verification system and method for infusions |
US7417729B2 (en) | 2003-11-07 | 2008-08-26 | Cardinal Health 303, Inc. | Fluid verification system and method for infusions |
US8020564B2 (en) | 2003-12-01 | 2011-09-20 | Carefusion 303, Inc. | System and method for analyzing medical treatment data |
JP4629582B2 (en) | 2003-12-10 | 2011-02-09 | パナソニック株式会社 | Anti-theft system |
US7959608B2 (en) | 2004-04-27 | 2011-06-14 | The Spectranetics Corporation | Thrombectomy and soft debris removal device |
US7713574B2 (en) | 2004-07-13 | 2010-05-11 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7970631B2 (en) | 2004-08-31 | 2011-06-28 | Ethicon Endo-Surgery, Inc. | Medical effector system |
EP1640029A1 (en) | 2004-09-24 | 2006-03-29 | Novo Nordisk A/S | Injection device with cap |
US20060073891A1 (en) * | 2004-10-01 | 2006-04-06 | Holt Timothy M | Display with multiple user privacy |
US7210166B2 (en) * | 2004-10-16 | 2007-04-24 | Lenovo (Singapore) Pte. Ltd. | Method and system for secure, one-time password override during password-protected system boot |
US20060195064A1 (en) | 2005-02-28 | 2006-08-31 | Fresenius Medical Care Holdings, Inc. | Portable apparatus for peritoneal dialysis therapy |
US7935074B2 (en) | 2005-02-28 | 2011-05-03 | Fresenius Medical Care Holdings, Inc. | Cassette system for peritoneal dialysis machine |
US7571486B2 (en) * | 2005-03-29 | 2009-08-04 | Microsoft Corporation | System and method for password protecting an attribute of content transmitted over a network |
US7594889B2 (en) | 2005-03-31 | 2009-09-29 | Medtronic, Inc. | Integrated data collection and analysis for clinical study |
WO2006110193A2 (en) | 2005-04-08 | 2006-10-19 | Dexcom, Inc. | Cellulosic-based interference domain for an analyte sensor |
US7945452B2 (en) | 2005-04-11 | 2011-05-17 | Hospira, Inc. | User interface improvements for medical devices |
WO2007000427A1 (en) | 2005-06-27 | 2007-01-04 | Novo Nordisk A/S | User interface for delivery system providing dual setting of parameters |
WO2007000426A2 (en) | 2005-06-27 | 2007-01-04 | Novo Nordisk A/S | User interface for delivery system providing shortcut navigation |
WO2007000425A2 (en) | 2005-06-27 | 2007-01-04 | Novo Nordisk A/S | User interface for delivery system providing graphical programming of profile |
US20070093786A1 (en) | 2005-08-16 | 2007-04-26 | Medtronic Minimed, Inc. | Watch controller for a medical device |
US20070088269A1 (en) | 2005-09-30 | 2007-04-19 | Sherwood Services Ag | Medical pump with lockout system |
US7630791B2 (en) | 2005-12-09 | 2009-12-08 | CareFusion 303 Inc. | System and method for storing items and tracking item usage |
FI120716B (en) * | 2005-12-20 | 2010-02-15 | Smart Valley Software Oy | A method for measuring and analyzing the movements of a human or animal using audio signals |
US8115600B2 (en) | 2008-11-19 | 2012-02-14 | Greatbatch Ltd. | RFID detection and identification system including an RFID reader having a limited transmit time and a time-out period to protect a medical device against RFID-associated electromagnetic interference |
US9839743B2 (en) | 2006-02-09 | 2017-12-12 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
ATE504325T1 (en) | 2006-02-09 | 2011-04-15 | Deka Products Lp | SYSTEMS FOR DISPENSING LIQUIDS IN PATCH SIZE |
WO2007121763A1 (en) | 2006-04-20 | 2007-11-01 | Lifescan Scotland Limited | Method for transmitting data in a blood glucose system and corresponding blood glucose system |
US7539533B2 (en) | 2006-05-16 | 2009-05-26 | Bao Tran | Mesh network monitoring appliance |
US8548544B2 (en) | 2006-06-19 | 2013-10-01 | Dose Safety | System, method and article for controlling the dispensing of insulin |
US7736338B2 (en) | 2006-08-23 | 2010-06-15 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US7515060B2 (en) | 2006-10-17 | 2009-04-07 | Smiths Medical Md, Inc. | Insulin pump for the visually impaired |
US20080172030A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having aweekly schedule |
US20080172031A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having correction factors |
US20080171967A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a food database |
US20080172027A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having basal rate testing features |
US20080172028A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having selectable insulin absorption models |
US20080172029A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump for determining carbohydrate consumption |
US7988674B2 (en) | 2006-10-30 | 2011-08-02 | Medtronic, Inc. | Externally releasable body portal anchors and systems |
EP1918837A1 (en) | 2006-10-31 | 2008-05-07 | F. Hoffmann-La Roche AG | Method for processing a chronological sequence of measurements of a time dependent parameter |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US20080119705A1 (en) | 2006-11-17 | 2008-05-22 | Medtronic Minimed, Inc. | Systems and Methods for Diabetes Management Using Consumer Electronic Devices |
CN101627386B (en) | 2006-12-14 | 2013-10-30 | 诺沃-诺迪斯克有限公司 | Device and method for displaying information and comprising diary function with time change feature |
US8562834B2 (en) | 2007-02-27 | 2013-10-22 | Deka Products Limited Partnership | Modular assembly for a portable hemodialysis system |
US20090107335A1 (en) | 2007-02-27 | 2009-04-30 | Deka Products Limited Partnership | Air trap for a medical infusion device |
US7957984B1 (en) | 2007-02-28 | 2011-06-07 | Anthony Vallone | Device for facilitating compliance with medication regimen |
US8390244B2 (en) | 2007-03-30 | 2013-03-05 | Nipro Healthcare Systems, Llc | Rechargeable battery backup apparatus and method for insulin pump |
US8034019B2 (en) | 2007-04-10 | 2011-10-11 | Amrita Vishwa Vidyapeetham | Dual microcontroller-based liquid infusion system |
JP5277242B2 (en) | 2007-04-30 | 2013-08-28 | メドトロニック ミニメド インコーポレイテッド | Needle insertion and fluid flow connections for infusion medium delivery systems |
US7963954B2 (en) | 2007-04-30 | 2011-06-21 | Medtronic Minimed, Inc. | Automated filling systems and methods |
CN101675438A (en) | 2007-05-03 | 2010-03-17 | 诺沃-诺迪斯克有限公司 | Safety system for insulin delivery advisory algoritms |
US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
ES2681895T3 (en) | 2007-06-18 | 2018-09-17 | F. Hoffmann-La Roche Ag | Glucose control method and system to monitor the individual metabolic response and to generate a nutritional response |
EP2170430A2 (en) | 2007-06-29 | 2010-04-07 | Roche Diagnostics GmbH | Method and apparatus for determining and delivering a drug bolus |
CN101801438B (en) | 2007-07-20 | 2013-08-07 | 梅丁格有限公司 | Manually operable portable infusion device |
US8147446B2 (en) | 2007-08-01 | 2012-04-03 | Medingo Ltd. | Detachable portable infusion device |
US9747743B2 (en) | 2007-08-03 | 2017-08-29 | Carefusion 303, Inc. | Patient-specific medication dispensing and notification system |
US7828528B2 (en) | 2007-09-06 | 2010-11-09 | Asante Solutions, Inc. | Occlusion sensing system for infusion pumps |
US7938792B2 (en) | 2007-10-01 | 2011-05-10 | Baxter International Inc. | Adaptive algorithm for access disconnect detection |
US20090085768A1 (en) | 2007-10-02 | 2009-04-02 | Medtronic Minimed, Inc. | Glucose sensor transceiver |
CA2702116C (en) | 2007-10-10 | 2021-01-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US9355218B2 (en) | 2007-10-30 | 2016-05-31 | Carefusion 303, Inc. | Secure medication transport and administration system |
US7875022B2 (en) | 2007-12-12 | 2011-01-25 | Asante Solutions, Inc. | Portable infusion pump and media player |
TWI400930B (en) * | 2007-12-28 | 2013-07-01 | Htc Corp | Handheld electronic device and screen locking method thereof |
EP2244765B1 (en) | 2007-12-31 | 2019-08-14 | DEKA Products Limited Partnership | Infusion pump assembly |
US20090177142A1 (en) | 2008-01-09 | 2009-07-09 | Smiths Medical Md, Inc | Insulin pump with add-on modules |
KR102060347B1 (en) | 2008-01-23 | 2019-12-30 | 데카 프로덕츠 리미티드 파트너쉽 | Pump cassette and methods for use in medical treatment system using a plurality of fluid lines |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US20090221890A1 (en) | 2008-02-28 | 2009-09-03 | Daniel Saffer | Diabetes Management System |
MX2010010858A (en) | 2008-04-01 | 2010-11-01 | Deka Products Lp | Methods and systems for controlling an infusion pump. |
KR20100127315A (en) | 2008-04-01 | 2010-12-03 | 스미스 메디칼 에이에스디, 인크. | Software features for medical infusion pump |
CN101587398A (en) * | 2008-05-23 | 2009-11-25 | 鸿富锦精密工业(深圳)有限公司 | Password protection method |
US7988849B2 (en) | 2008-06-03 | 2011-08-02 | Baxter International Inc. | Customizable personal dialysis device having ease of use and therapy enhancement features |
US8130095B2 (en) | 2008-08-27 | 2012-03-06 | The Invention Science Fund I, Llc | Health-related signaling via wearable items |
US8094009B2 (en) | 2008-08-27 | 2012-01-10 | The Invention Science Fund I, Llc | Health-related signaling via wearable items |
WO2010031059A2 (en) | 2008-09-15 | 2010-03-18 | Deka Products Limited Partnership | Systems and methods for fluid delivery |
US8310415B2 (en) | 2008-09-30 | 2012-11-13 | Animas Corporation | Medical devices using bistable displays |
US9833569B2 (en) | 2008-10-10 | 2017-12-05 | Deka Products Limited Partnership | Infusion pump assembly |
US8744629B2 (en) | 2008-10-27 | 2014-06-03 | Lennox Industries Inc. | System and method of use for a user interface dashboard of a heating, ventilation and air conditioning network |
WO2010054314A1 (en) | 2008-11-10 | 2010-05-14 | Delphi Technologies, Inc. | Method of inputting data into an infusion pump |
CN201319516Y (en) | 2008-11-26 | 2009-09-30 | 广州西格美信电子科技有限公司 | Self-adapting external battery for mobile devices |
US8096987B2 (en) | 2008-12-05 | 2012-01-17 | The Alfred E. Mann Foundation For Scientific Research | Methods and apparatus for translating a continuous-delivery into a plurality of periodic bolus deliveries |
US8066197B2 (en) | 2009-01-15 | 2011-11-29 | Dana Canada Corporation | Failsafe thermal bypass valve for cooling system |
EP4043878A1 (en) | 2009-02-25 | 2022-08-17 | The University of Virginia Patent Foundation | Method, system and computer program product for cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery |
CA2753214C (en) | 2009-02-27 | 2017-07-25 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
WO2010132617A2 (en) | 2009-05-12 | 2010-11-18 | Chronicmobile, Inc. | Methods and systems for managing, controlling and monitoring medical devices via one or more software applications functioning in a secure environment |
US8636661B2 (en) | 2009-06-04 | 2014-01-28 | Roche Diagnostics Operations, Inc. | Embeddable modules for measuring blood glucose levels |
CN102461133A (en) * | 2009-06-26 | 2012-05-16 | 诺基亚公司 | Method, apparatus and computer program code handling a user input |
US20110009724A1 (en) | 2009-07-09 | 2011-01-13 | Medtronic Minimed, Inc. | Providing contextually relevant advertisements and e-commerce features in a personal medical device system |
US8344847B2 (en) | 2009-07-09 | 2013-01-01 | Medtronic Minimed, Inc. | Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device |
US8356644B2 (en) | 2009-08-07 | 2013-01-22 | Medtronic Minimed, Inc. | Transfer guard systems and methods |
US8932256B2 (en) | 2009-09-02 | 2015-01-13 | Medtronic Minimed, Inc. | Insertion device systems and methods |
FI3920471T3 (en) | 2009-09-08 | 2024-02-07 | Abbott Diabetes Care Inc | Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device |
US20110098637A1 (en) | 2009-10-27 | 2011-04-28 | Medtronic Minimed, Inc. | Method and System for Configuring an Insulin Infusion Device |
US20110098638A1 (en) | 2009-10-27 | 2011-04-28 | Medtronic Minimed, Inc. | Sensor-Augmented Medication Infusion System |
US20110098674A1 (en) * | 2009-10-27 | 2011-04-28 | Medtronic Minimed, Inc. | Method and System for Programming an Infusion Device |
US8209060B2 (en) | 2009-11-05 | 2012-06-26 | Smiths Medical Asd, Inc. | Updating syringe profiles for a syringe pump |
US8552880B2 (en) | 2009-12-04 | 2013-10-08 | Smiths Medical Asd, Inc. | Guided user help system for an ambulatory infusion system |
US8882701B2 (en) | 2009-12-04 | 2014-11-11 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
EP3085402B1 (en) | 2009-12-31 | 2018-05-09 | DEKA Products Limited Partnership | Infusion pump assembley |
US11244745B2 (en) | 2010-01-22 | 2022-02-08 | Deka Products Limited Partnership | Computer-implemented method, system, and apparatus for electronic patient care |
US10453157B2 (en) | 2010-01-22 | 2019-10-22 | Deka Products Limited Partnership | System, method, and apparatus for electronic patient care |
US8828330B2 (en) | 2010-01-28 | 2014-09-09 | Abbott Diabetes Care Inc. | Universal test strip port |
WO2011119679A1 (en) * | 2010-03-25 | 2011-09-29 | Chen David H C | Systems, devices, and methods of energy management, property security and fire hazard prevention |
US20110256024A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Modular Analyte Monitoring Device |
US20120041427A1 (en) | 2010-04-20 | 2012-02-16 | Minipumps, Llc | Electrolytically driven drug pump devices |
US8811948B2 (en) * | 2010-07-09 | 2014-08-19 | Microsoft Corporation | Above-lock camera access |
TWI437230B (en) * | 2010-07-29 | 2014-05-11 | Chi Mei Comm Systems Inc | System and method for unlocking the portable electronic devices |
US20120084728A1 (en) | 2010-10-05 | 2012-04-05 | Wen-Liang Huang | Button control system for medical touch screen and method thereof |
US8401194B2 (en) | 2010-10-15 | 2013-03-19 | Roche Diagnostics Operations, Inc. | Diabetes care kit that is preconfigured to establish a secure bidirectional communication link between a blood glucose meter and insulin pump |
US20120095315A1 (en) | 2010-10-15 | 2012-04-19 | Roche Diagnostics Operations, Inc. | Configuration of blood glucose meter interfaces |
EP2641151A4 (en) | 2010-11-19 | 2018-04-18 | Spacelabs Healthcare LLC | Self-contained patient monitor |
WO2012092197A2 (en) | 2010-12-27 | 2012-07-05 | Medtronic, Inc. | Application limitations for a medical communication module and host device |
KR101830651B1 (en) * | 2011-01-04 | 2018-02-21 | 엘지전자 주식회사 | Information displaying apparatus and method thereof |
US8852152B2 (en) | 2011-02-09 | 2014-10-07 | Asante Solutions, Inc. | Infusion pump systems and methods |
US10010273B2 (en) | 2011-03-10 | 2018-07-03 | Abbott Diabetes Care, Inc. | Multi-function analyte monitor device and methods of use |
WO2012166729A1 (en) * | 2011-05-31 | 2012-12-06 | Callyo 2009 Corp. | Mobile phone as a one-way recorded transmitter over a cellular network |
US20130053816A1 (en) | 2011-07-25 | 2013-02-28 | Tandem Diabetes Care, Inc. | Multi-reservoir infusion pump systems and methods |
US9136939B2 (en) | 2011-12-29 | 2015-09-15 | Roche Diabetes Care, Inc. | Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device |
EP3974018A1 (en) | 2012-03-07 | 2022-03-30 | DEKA Products Limited Partnership | Infusion pump assembly |
US9335910B2 (en) | 2012-04-23 | 2016-05-10 | Tandem Diabetes Care, Inc. | System and method for reduction of inadvertent activation of medical device during manipulation |
US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
US9715327B2 (en) | 2012-06-07 | 2017-07-25 | Tandem Diabetes Care, Inc. | Preventing inadvertent changes in ambulatory medical devices |
US20140012117A1 (en) | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
US8454557B1 (en) | 2012-07-19 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump system and method |
US9940441B2 (en) | 2013-03-13 | 2018-04-10 | Tandem Diabetes Care, Inc. | System and method for maximum insulin pump bolus override |
US10357606B2 (en) | 2013-03-13 | 2019-07-23 | Tandem Diabetes Care, Inc. | System and method for integration of insulin pumps and continuous glucose monitoring |
US9565718B2 (en) | 2013-09-10 | 2017-02-07 | Tandem Diabetes Care, Inc. | System and method for detecting and transmitting medical device alarm with a smartphone application |
EP3087548A4 (en) | 2013-12-26 | 2017-09-13 | Tandem Diabetes Care, Inc. | Safety processor for wireless control of a drug delivery device |
EP3086828B1 (en) | 2013-12-26 | 2023-08-09 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US10994077B2 (en) | 2016-07-21 | 2021-05-04 | Tandem Diabetes Care, Inc. | Enhanced confirmations for touchscreen infusion pump |
-
2013
- 2013-03-13 US US13/801,230 patent/US9715327B2/en active Active
- 2013-06-05 EP EP13800236.5A patent/EP2858697B1/en active Active
- 2013-06-05 WO PCT/US2013/044329 patent/WO2013184812A1/en active Application Filing
- 2013-06-05 EP EP19186132.7A patent/EP3584797A3/en not_active Ceased
-
2017
- 2017-05-11 US US15/592,595 patent/US10430043B2/en active Active
-
2019
- 2019-09-17 US US16/573,621 patent/US20200012401A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024229A2 (en) * | 1994-03-09 | 1995-09-14 | Baxter International Inc. | Ambulatory infusion pump |
WO2000018449A2 (en) * | 1998-09-30 | 2000-04-06 | Minimed Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US20120109100A1 (en) * | 2007-09-06 | 2012-05-03 | Asante Solutions, Inc. | Operating A Portable Medical Device |
US20110047499A1 (en) * | 2008-04-01 | 2011-02-24 | Deka Products Limited Partnership | Infusion pump methods and systems |
US20120030610A1 (en) * | 2009-07-30 | 2012-02-02 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108134950A (en) * | 2017-12-07 | 2018-06-08 | 上海斐讯数据通信技术有限公司 | A kind of intelligent video recommends method and system |
CN108134950B (en) * | 2017-12-07 | 2022-05-06 | 广州锐竞信息科技有限责任公司 | Intelligent video recommendation method and system |
Also Published As
Publication number | Publication date |
---|---|
US10430043B2 (en) | 2019-10-01 |
EP3584797A2 (en) | 2019-12-25 |
EP2858697A1 (en) | 2015-04-15 |
US9715327B2 (en) | 2017-07-25 |
EP2858697A4 (en) | 2017-07-05 |
US20170300206A1 (en) | 2017-10-19 |
US20130332874A1 (en) | 2013-12-12 |
EP3584797A3 (en) | 2020-03-11 |
EP2858697B1 (en) | 2019-08-21 |
US20200012401A1 (en) | 2020-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10430043B2 (en) | Preventing inadvertent changes in ambulatory medical devices | |
US20240038380A1 (en) | System and method for reduction of inadvertent activation of medical device during manipulation | |
US20210252218A1 (en) | Enhanced confirmations for touchscreen infusion pump | |
US20230047136A1 (en) | System and method for maximum insulin pump bolus override | |
JP5893567B2 (en) | Medical pump system | |
AU2016226317B2 (en) | Infusion system, device, and method having advanced infusion features | |
US11801341B2 (en) | User experience for infusion pumps | |
US20200384190A1 (en) | System and method for operating controller of delivery device having swipe and tap to confirm feature | |
US20210316068A1 (en) | Infusion pump and infusion pump operations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13800236 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013800236 Country of ref document: EP |